TLR4 deficiency protects against doxorubicin-induced cardiomyopathy in a mouse model.
TLR4 deficiency improves left ventricular function and attenuates pathophysiological key mechanisms in Dox-induced cardiomyopathy.
Riad et al. (Sat,) studied this question.